Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 14.93 is 28% above its 3-year average of 11.65, around the middle of its 3-year range (6.51–32.01).
As of the fiscal period ended Tuesday, June 30, 2026. 8.39% above its 12-month average of 13.77.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 14.93.
CURRENT RATIO
14.93
CURRENT RATIO AVG TTM
13.77
CURRENT RATIO AVG 3Y
11.65
CURRENT RATIO AVG 5Y
N/A
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+8.39%
CURRENT VS 3Y AVG
+28.16%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.67
median of 822 covered companies
CURRENT VS SECTOR MEDIAN
+306.18%
vs the sector median at left
Jade Biosciences, Inc.
Market Cap
$803.69M
Current Ratio
14.93
TTM Avg
13.77
3Y Avg
11.65
5Y Avg
N/A
Market Cap
$789.31M
Current Ratio
4.26
TTM Avg
4.46
3Y Avg
3.96
5Y Avg
4.08
Market Cap
$827.75M
Current Ratio
4.92
TTM Avg
7.19
3Y Avg
6.36
5Y Avg
8.34
Market Cap
$830.54M
Current Ratio
9.52
TTM Avg
4.26
3Y Avg
6.09
5Y Avg
7.80
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Jade Biosciences, Inc. (JBIO) | $803.69M | 14.93 | 13.77 | 11.65 | N/A |
| InMode Ltd. (INMD)vs › | $804.44M | 8.18 | 10.05 | 10.24 | 9.72 |
| Ardelyx, Inc. (ARDX)vs › | $802.13M | 3.34 | 4.45 | 4.03 | 4.25 |
| AdaptHealth Corp. (AHCO)vs › | $792.51M | 1.12 | 1.18 | 1.21 | 1.17 |
| Gyre Therapeutics, Inc. (GYRE)vs › | $789.31M | 4.26 | 4.46 | 3.96 | 4.08 |
| Geron Corporation (GERN)vs › | $785.86M | 6.92 | 5.11 | 3.93 | 4.38 |
| Pacific Biosciences of California, Inc. (PACB)vs › | $827.75M | 4.92 | 7.19 | 6.36 | 8.34 |
| Monte Rosa Therapeutics, Inc. (GLUE)vs › | $830.54M | 9.52 | 4.26 | 6.09 | 7.80 |
| Beta Bionics, Inc. (BBNX)vs › | $830.96M | 8.88 | 7.47 | 6.98 | 6.98 |
| Alumis Inc. (ALMS)vs › | $834.31M | 6.74 | 5.17 | 5.15 | 5.15 |
Current Ratio
14.93
Quick Ratio
14.93
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 14.93 |
| 2026-03-31 | 14.29 |
| 2025-12-31 | 20.33 |
| 2025-09-30 | 9.01 |
| 2025-06-30 | 10.31 |
| 2025-03-31 | 32.01 |
| 2024-12-31 | 20.93 |
| 2024-09-30 | 8.78 |
| 2024-06-30 | 6.51 |
| 2024-03-31 | 6.65 |
| 2023-12-31 | 7.04 |
| 2023-09-30 | 9.34 |
